OFI Advisors’s ResMed RMD Stock Holding History

OFI Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$283K	Buy	5,555 +454	+9%	+$24.4K	0.02%	1021
2015 Q2	$288K	Buy	5,101 +1,230	+32%	+$77.6K	0.02%	1057
2015 Q1	$278K	Sell	3,871 -598	-13%	-$38.8K	0.02%	1070
2014 Q4	$251K	Sell	4,469 -632	-12%	-$33K	0.02%	1083
2014 Q3	$251K	Buy	5,101 +319	+7%	+$16.2K	0.02%	1022
2014 Q2	$242K	Sell	4,782 -335	-7%	-$16.6K	0.02%	1059
2014 Q1	$229K	Buy	5,117 +988	+24%	+$44.4K	0.02%	1036
2013 Q4	$194K	Buy	4,129 +1,044	+34%	+$52.8K	0.02%	1101
2013 Q3	$163K	Sell	3,085 -875	-22%	-$42.4K	0.02%	1091
2013 Q2	$179K	Buy	+3,960	New	+$188K	0.02%	943

Other funds holding RMD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

OFI Advisors's RMD Position: Q3 2015 in Review

OFI Advisors increased its ResMed (RMD) stake by 8.9% in Q3 2015, buying an estimated $24.4K and bringing the position to 5,555 shares worth $283K. The position accounts for 0.02% of the portfolio, ranked #1021.

OFI Advisors first reported a position in RMD in Q2 2013 and has held it in 10 quarters since. The position peaked at $288K in Q2 2015. 313 funds tracked by Wall St. Rank hold RMD as of Q3 2015.

OFI Advisors held 5,555 shares of ResMed worth $283K as of Q3 2015.
OFI Advisors bought 454 ResMed shares in Q3 2015, an estimated $24.4K.
ResMed made up 0.02% of OFI Advisors's portfolio in Q3 2015, its #1021 holding.
OFI Advisors first reported a position in ResMed in Q2 2013 and has held it in 10 quarters since.
OFI Advisors's ResMed position peaked at $288K in Q2 2015.
313 funds tracked by Wall St. Rank held ResMed as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.